Figure 3From: Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancerExpression of NFAT5 protein in normal and cancer breast specimens spotted on TMA. NFAT5 protein staining was evaluated by immunohistochemistry in 39 IBC, 82 nIBC and 15 normal breast specimens (Norm). A: The percentage of NFAT5-positive and NFAT5-negative cases. B-C: Percentage of NFAT5 subcellular staining detected on TMA validation series. The p-values reported in each graph were obtained by chi-square test with Yates’s correction for continuity between IBC and nIBC group. D: NFAT5 subcellular immunostaining pattern: cytoplasmic (C), nuclear/cytoplasmic (N/C), nuclear (N) or negative (Neg).Back to article page